# US 6,727,222 B2 · Transcriptional regulator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,222 B2
- Document ID: US6727222B2
- Status: Granted
- Kind: B2
- Application number: 09/839,479
- Filed: 2001-04-20
- Published: 2002-04-04
- Granted: 2004-04-27
- Earliest claimed: 1997-04-18
- Assignees: Chugai Seiyaku Kabushi Kaisha
- Inventors: Michael H. Jones
- Web page: https://patentgrep.com/patent/US6727222B2

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K 14/4702: {Regulators; Modulating activity}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Genes each encoding a novel transcriptional regulator having a bromodomain have been successfully isolated from a human testis cDNA library using primers prepared based on an EST sequence found using the bromodomain sequence of the transcriptional regulator. These genes are structurally analogous to each other.

## Claims

### Claim 1

A substantially pure polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:1, wherein the polypeptide regulates transcription of a gene and comprises a bromodomain.

### Claim 2

A substantially pure polypeptide comprising SEQ ID NO:1.

### Claim 3

A substantially pure polypeptide comprising the amino acid sequence of SEQ ID NO:1, with up to 30 conservative amino acid substitutions, wherein the polypeptide regulates transcription of a gene and comprises a bromodomain.

### Claim 4

A substantially pure polypeptide encoded by a nucleic acid that hybridizes under high stringency conditions (65° C., 2×SSC) to a nucleotide sequence consisting of the complement of the coding sequence of SEQ ID NO:2, wherein the polypeptide regulates transcription of a gene and comprises a bromodomain.

### Claim 5

A substantially pure polypeptide consisting of the sequence of SEQ ID NO:1.

### Claim 6 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide comprises a C4HC3 zinc finger domain, a leucine zipper (LXXLL) domain, and a nuclear transport signal.

### Claim 7 (depends on 3)

The polypeptide of claim 3, wherein the polypeptide comprises a C4HC3 zinc finger domain, a leucine zipper (LXXLL) domain, and a nuclear transport signal.

### Claim 8 (depends on 4)

The polypeptide of claim 4, wherein the polypeptide comprises a C4HC3 zinc finger domain, a leucine zipper (LXXLL) domain, and a nuclear transport signal.

### Claim 9 (depends on 1)

A method of screening for a compound that binds to a polypeptide, the method comprising:
providing the polypeptide of claim 1;
contacting a test compound with the polypeptide; and
determining whether the test compound binds the polypeptide.

### Claim 10 (depends on 2)

A method of screening for a compound that binds to a polypeptide, the method comprising:
providing the polypeptide of claim 2;
contacting a test compound with the polypeptide; and
determining whether the test compound binds the polypeptide.

### Claim 11 (depends on 3)

A method of screening for a compound that binds to a polypeptide, the method comprising:
providing the polypeptide of claim 3;
contacting a test compound with the polypeptide; and
determining whether the test compound binds the polypeptide.

### Claim 12 (depends on 4)

A method of screening for a compound that binds to a polypeptide, the method comprising:
providing the polypeptide of claim 4;
contacting a test compound with the polypeptide; and
determining whether the test compound binds the polypeptide.

### Claim 13 (depends on 5)

A method of screening for a compound that binds to a polypeptide, the method comprising:
providing the polypeptide of claim 5;
contacting a test compound with the polypeptide; and
determining whether the test compound binds the polypeptide.
